CTNM
Price
$15.49
Change
-$0.26 (-1.65%)
Updated
Jul 31 closing price
Capitalization
582.75M
15 days until earnings call
Intraday BUY SELL Signals
GPCR
Price
$48.04
Change
-$1.43 (-2.89%)
Updated
Jul 31 closing price
Capitalization
3.41B
3 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTNM vs GPCR

CTNM vs GPCR Comparison Chart in %
View a ticker or compare two or three
VS
CTNM vs. GPCR commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a Hold and GPCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (CTNM: $15.49 vs. GPCR: $48.04)
Brand notoriety: CTNM and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 79% vs. GPCR: 38%
Market capitalization -- CTNM: $582.75M vs. GPCR: $3.41B
CTNM [@Biotechnology] is valued at $582.75M. GPCR’s [@Biotechnology] market capitalization is $3.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whileGPCR’s FA Score has 1 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • GPCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both CTNM and GPCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 6 TA indicator(s) are bullish while GPCR’s TA Score has 4 bullish TA indicator(s).

  • CTNM’s TA Score: 6 bullish, 4 bearish.
  • GPCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CTNM is a better buy in the short-term than GPCR.

Price Growth

CTNM (@Biotechnology) experienced а +10.17% price change this week, while GPCR (@Biotechnology) price change was -2.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

CTNM is expected to report earnings on Aug 18, 2026.

GPCR is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($3.41B) has a higher market cap than CTNM($583M). CTNM YTD gains are higher at: 35.521 vs. GPCR (-30.927). CTNM has higher annual earnings (EBITDA): -66M vs. GPCR (-218.24M). GPCR has more cash in the bank: 1.46B vs. CTNM (237M). GPCR has less debt than CTNM: GPCR (5.79M) vs CTNM (6.57M). CTNM (0) and GPCR (0) have equivalent revenues.
CTNMGPCRCTNM / GPCR
Capitalization583M3.41B17%
EBITDA-66M-218.24M30%
Gain YTD35.521-30.927-115%
P/E Ratio26.40N/A-
Revenue00-
Total Cash237M1.46B16%
Total Debt6.57M5.79M114%
TECHNICAL ANALYSIS
Technical Analysis
CTNMGPCR
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VALG17.730.11
+0.64%
Leverage Shares 2X Long VALE Daily ETF
DMAR45.030.14
+0.31%
FT Vest US Equity Deep Bffr ETF Mar
EWU48.41-0.27
-0.55%
iShares MSCI United Kingdom ETF
LIAM229.08-2.17
-0.94%
LifeX 2055 Infl-Prt Longevity Income ETF
IBLC43.36-1.28
-2.87%
iShares Blockchain and Tech ETF

CTNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTNM has been loosely correlated with PMN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CTNM jumps, then PMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
-1.65%
PMN - CTNM
34%
Loosely correlated
-8.04%
ZURA - CTNM
33%
Poorly correlated
-1.99%
PHVS - CTNM
32%
Poorly correlated
-3.72%
CNTB - CTNM
29%
Poorly correlated
-3.35%
GPCR - CTNM
28%
Poorly correlated
-2.89%
More

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with WVE. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
-2.89%
WVE - GPCR
65%
Loosely correlated
-4.34%
KYMR - GPCR
60%
Loosely correlated
-3.37%
NRIX - GPCR
45%
Loosely correlated
-1.57%
OCUL - GPCR
45%
Loosely correlated
-3.54%
FULC - GPCR
41%
Loosely correlated
-3.76%
More